Proc. Nadl. Acad. Sci. USA
Vol. 82, pp. 4189-4192, June 1985
Genetics



Bacillus subtilis factor CF29 product sporulation-essential gene spoIIG
     (bacterial sporulation/monoclonal antibody)
JANINE E. TREMPY*, CELINE BONAMYt, JEKISIEL SZULMAJSTERt, WILLIAM G. HALDENWANG*
*Department Microbiology, University Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284; tLaboratoire d'Enzymologie
du Centre National la Recherche Scientifique, 91190 Gif-Sur-Yvette, France
Communicated Jesse C. Rabinowitz, February 22, 1985

ABSTRACT           Evidence presented sporulation-                       early stage development lie map position 130
essential locus spolIG codes 29 structurally                          B. subtilis chromosome (10, 11). sporulation-es-
related protein, P31. demonstrates specific                   sential gene recently cloned sequenced (12).
Bacilus subtilis RNA polymerase binding protein provides                           likely product spolIG, inferred DNA sequence
critical function endospore formation. spoIIG-specific RNA                        data, Mr 27,500 protein carries regions homology present B. subtilis cultures synthesizing p3'                     major E. coli ar factor encoded rpoD (12). Based 29 absent  monoclonal antibody                      size, time expression, homology rpoD, spoIIG
specific antigenic determinant P31/cr29 detected                           suggested structural gene or29 (12).
crossreacting proteins (P25/P21) P3' cy29 Spo- B.                      analyzed possible relationship subtilis strain mutation spolIG locus (spoIIG41).                      spoIIG o.29 monoclonal antibody (8) specific appearance P25 P21 occurs mutant time                        antigenic site exclusively present P3' ,29. P31 Ca29 normally appear suggests                            experiments indicate sporulation-essential locus homologous proteins. Transformation spoIlG41                         spoIIG structural gene P31 o,29.  strain plasmid DNA carrying structural gene                             proteins play critical role endospore
spolIG complements Spo- phenotype results                             formation.
synthesis P31, 29 p25, P21 appropriate times sporulation. Escherichia coli, cloned spolIG                                        MATERIALS METHODS
sequence encoded protein reacted anti-P31/Oa'29
monoclonal antibody electrophoretic mobility                            Bacterial Strains. B. subtilis strains BS50 (spoIIG41) authentic P31.                                                                       BS119 (spoIIG55) obtained M. Young; SMY                                                                                      R. Losick; NG 17.15, P9, 26U spore-forming bacterium Bacillus subtilis synthesizes                         Bacillus Stock Center (Ohio State University). E. coli strain forms DNA-dependent RNA polymerase,                              C600 obtained B. Eisenstein. relevant pheno- distinguished promoter specificity determinant (o,                        types strains indicated figure legends.
factor) carries common core enzyme (1-5).                                RNA Analysis. B. subtilis cells grown Sterlini  factors, cr29, protein (Mr, 29,000)                       Mandelstam resuspension medium (13). RNA vegeta-
detected endospore formation                           tive sporulating [2 hr (T2) 4 hr (T4) sporulation]
predicted important element spore gene regulation                        cells prepared described Gilman Chamberlin
(3, 6, 7). Recently, protein (P31; Mr, 31,000), structurally                       (4) disruption cells passage Eaton
related v.29, identified extracts sporulating B.                        pressure cell (5000 psi; 1 psi = 6.895 x 103 Pa). RNA subtilis (8). p31 reacts monoclonal antibody                          spotted nitrocellulose probed spoIIG-specific
specific antigenic site or29. addition, p31 o,29                    DNA [1.1-kilobase-pair Pst fragment (12)] labeled peptide profiles digested                             nick-translation reaction DNA polymerase 
Staphylococcus aureus V8 chymotrypsin A4 protease (ref.                              Analysis Cell Extracts Monoclonal Antibody. 9; unpublished results). sporulation, synthesis p31                        isolation production monoclonal antibody, precedes 29 occurs Bacillus species B.                      methods cell extract preparation analysis, subtilis Spo- mutants capable                                described (8).
synthesizing or29-like protein (8). p31, like ao29, capable associating core RNA polymerase. RNA polymerase                                                           RESULTS carries P3' (E-p31) elution pattern DNA-cel-
lulose identical RNA polymerase carrying ar29                             p31 or29 appear B. subtilis early stage (E-a29) (9). P31 29 differ biochemically P3' binds                     sporulation absent vegetatively growing cells (8).
relatively poorly RNA polymerase resulting E-P31                           spoIIG codes p31 29, RNA homologous detectable activity cloned B. subtilis DNAs (9).                       spoIIG DNA present sporulating cells.
properties p31 o29 indicate likely                    RNA extracted vegetatively growing sporulat-
products structural gene, p31 potentially                        ing cells (T2 T4), spotted nitrocellulose paper, inactive precursor cr29.                                                          hybridized 32P-labeled spoIIG DNA. Fig. 1 shows    genetic locus spoIIG defined number                                spoIIG sequence absent RNA obtained independently isolated mutations block spore formation                          vegetatively growing cells (lane 1), present 2 hr
                                                                                     sporulation (lane 2). number B. subtilis Spo-
 publication costs article defrayed page charge          mutants, blocked morphological stage develop-
 payment. article marked "advertisement"               ment (stage II), vary ability synthesize p31 a29
 accordance 18 U.S.C. ยง1734 solely indicate fact.                    (8). mutants probed spoIIG-specific
                                                                              4189
4190      Genetics:   Trempy et al.                                                       Proc. Natl. Acad. Sci. USA 82 (1985)
                                                                                                   _      3     4      -5     6

                                        ANOL.    ANIL.
                                        JIM"..   0
                                   rl   w


                                                                                                                                             p., 
                                                                                                                                                  2(
                                                                                                                                             (T
                                                                             p1i
                                                         -_-- 4              p'-   _I&




                                                         -*o    6

                                                         -46-   11

                                                                              FIG. 2. Immunological analysis o 29/P3' spoIIG mutants.
                                                                           Crude protein extracts prepared described (8) B.
                                                                           subtilis cells harvested 2 hr (T2) 3.5 hr (T3.5)                                                                            onset sporulation DS medium (15). Portions (100 /Ag)                                                    p:           t3
                                                                           fractionated electrophoresis 12  NaDodSO4/polyacrylamide
                                                          .-
                                                                           gels, transferred electrophoretically nitrocellulose, probed
                                                                           monoclonal antibody (8). Bound antibody visualized                                                            -    10         horseradish peroxidase-conjugated goat IgG mouse Ig
                                                                           (HyClone). Lanes: 1 2, BS119 (spoIIG55) T2 T3.5, respec-
                                                                           tively; 3 4, BS50 (spoIIG41) T2 T3.5, respectively; 5 6,
                                                         ~-     11         SMY (Spo+) T2 T3.5, respectively.

                                                                           strain (Fig. 3A) spoIIG41 mutant (Fig. 3B).                                                                            expected homologous proteins, pattern synthesis                                                                            proteins capable reacting monoclonal antibody
  FIG. 1. Dot blot analysis B. subtilis RNA spolIG            se-
                                                                           appears similar Spo+ mutant strains, quences. Increasing amounts RNA (1.25, 2.5, 5, 10, 20, 40 ,Lg
                                                                           synthesis p31 p25 preceding appearance .29 spot) vegetative cells cells harvested 2 hr (T2)     p21.
4 hr (T4) sporulation spotted nitrocellulose paper         spoIIG cloned DNA isolated sequence hybridized 6.7 x 106 cpm 32P-labeled spofIG DNA. Lanes:            corrected Spo- phenotype spoIIG mutations
1-3, B. subtilis 168M (Spo+) (vegetative, T2, T4); 4-6, B. subtilis NG     (spoIIG41 spoIIGSS) vivo (12). pGSIIG11 B.
17.15 (spoIIE64-oI29 absent, P31 present) (vegetative, T2, T4); 7-9, B.    subtilislE. coli shuttle plasmid carries entire spolIG
subtilis P9 (spoIIC298-o29 p31 present) (vegetative, T2, T4);          structural gene sequence, plus 100 200 base pairs B.
10-12, B. subtilis 26u (spoIIA26-o 29 p31 absent) (vegetative, T2,     subtilis DNA flank end gene, cloned
T4).                                                                       1.1-kilobase-pair DNA fragment (12). pGSIIG11                                                                            introduced spoIIG41 strain, transformants syn-
RNA, spoIIG RNA present end                   thesize p25 p21 proteins mobility
exponential growth mutant strain synthesizes p31             authentic p31 29 (Fig. 4, lanes 1 2).  Co29 (spoIIC; lanes 7-9) p31 (spoIIE; lanes 4-6),          plasmid DNA sequence did affect synthesis strain fails synthesize proteins              defective P31/cr29 proteins instead supplemented (spoIIA; lanes 10-12). spoIIG RNA present cells                 synthesis normal sized p31 cr29. simplest synthesizing P31/cr29 absent cells            explanation results, given physical similarities
   prepared crude protein extracts B.                     p31 a29, spoIIG defines structural
subtilis strains carry mutant alleles spoIIG (spoIIG41             gene p31 o.29 gene defective spoIIG55) analyzed size-fractionation                   spoIIG41 mutant. Possibly, spoIIG41 carries nonsense
NaDodSO4/polyacrylamide gels followed transfer ni-                   mutation leading synthesis truncated p31  e., P25)
trocellulose paper probing anti-o-29/P31 mono-                 cr29  e., p21).
clonal antibody. antibody readily detects p31 29                able verify directly structural gene extracts sporulating B. subtilis (Fig. 2, lanes 5 6).               P31 carried pGSIIG11 introducing plasmid E. spolIG mutants synthesized detectable                       coli screening extracts plasmid-containing strains amounts p31 v.29 (lanes 1-4),                   anti-P31/cr29 antibody. E. coli carried plasmid syn-
(spoIIG41) produced proteins [Mr, 25,000 (p25); Mr,                    thesized protein reacted antibody 21,000 (p21)] reacted o29/P31-specific antibody              electrophoretic properties authentic P31 (Fig. 4, lane 4).
(lanes 3 4). presence mutant aberrantly                 spoIIG sequence carried pGSIIG11 cloned sized proteins react o-29/P31-specific antibody absence p31 o.29 suggest spoIIG defect             8-lactamase gene plasmid vector (12). Expression directly affect synthesis p31 cr29.                  p3' protein E. coli transcription
   previously determined p31 r29 appear                 initiating 3-lactamase promoter. transcriptional precise time endospore formation (8). proteins              fusion ,-lactamase spoIIG account spoIIG41 strain recognized P31/29                      observation spoIIG-specific RNA present antibody similarly regulated, argue                vegetative B. subtilis cells carry pGSIIG11 (unpub-  fact, counterparts p31 o.29 mutant.            lished data). pGSIIG11 leads synthesis Fig. 3 shows analysis temporal appearance                 p31 29 spoIIG41 strain, unable proteins react anti-o-29 antibody Spo+ B. subtilis          detect u29 pGSIIG11-containing E. coli strain. Presum-
                 Genetics:     Trempy et                                                    Proc. Natl. Acad. Sci. USA 82 (1985)            4191

                               T1            T3                           endospore formation B. subtilis (16). data presented                                                                               paper support suggestion. report                                                                                 RNA polymerase binding proteins P3' -29                                                                                 products sporulation essential locus (spoIIG).
                                                                                    development heat-resistant endospores B. subtilis
                                                                  pTl           occurs -8 hr onset differentiation. Spo- mutants
                                                                                blocked stage II development (e.g., spolIG) char-
                                                                                acterized ability divide forespore mother
                                                                                cell compartments unable develop                                                                                 point (17). asymmetric cell division normally ac-
                                                                                complished second hour development (T2) (18). T2
                                                                                time o29 abundant sporulating
                                                                                cells (8).  defect sporulation does prevent
                                                                                cells reaching stage II arrests development                                                                                 stage expected phenotype associated                                                                                 loss o.29 function  e., interruption sporulation T2).
                                                                                     Previous biochemical evidence supported present
                                                                                study indicates P3' v.29 products                        B                                                        structural gene (8, 9). apparent structural gene                                                                                 proteins cloned sequenced,                                                                                 survey primary structure spolIG product                                                                                 characteristics bear speculation c 29
                                                                                derived P31. obvious modification                                                                                 yield cr29 proteolysis ends                                                                                 P3' molecule. "truncated" proteins                                                             -+- Pr-             spoIIG41 mutant (p25 p2l) counterparts P3'                                                                                   29 result proteolytic degradation mutant
                                                                                protein, argued amino-terminal
                                                            _--    P21           portion molecule critical region processing.
                                                                                 Limited digestion P31 S. aureus V8 protease results
                                                                                 generation protein carries P311/o29
                                                                                 common epitope electrophoretic mobility similar
  FIG. 3. Time               course   p31/cI29 accumulation. Crude protein    29 (ref. 9; unpublished results). protein extracts (100 jig) SMY (Spo')   BS50 (spoIIG4l) (B),                   slowly digested overlapping peptides, harvested hourly intervals sporulation DS medium (15),              represent partial digestion products identifiable size-fractionated NaDodSO4/PAGE (15  acrylamide),                        anti-P31/af29 monoclonal antibody. peptides
transferred nitrocellulose, probed anti 29 antibody             appear identical digestion products obtained described Fig. 1.  end exponential growth; T1, 1 hr           similar reaction authentic a29 (8, 9). late                                                                           digestion products P3' cr29 appear 
                                                                                 distinguishable, assume Mr
ably, E. coli lacks necessary factor synthesize a29                   29,000 initial digestion product p31 protein process             P31.                                              similar authentic a2.
                                                                                     S. aureus V8 protease specifically cleaves peptide bonds
                                      DISCUSSION                                 carboxyl-terminal site aspartic acid                                                                                  glutamic acid (19). predicted amino acid sequence suggested RNA polymerase modification                        spoIIG gene product (12) examined, S. aureus protease critical mechanism(s) activating genes                      cleavage site 24 amino acids amino-
                                                                                 terminal end molecule (Fig. 5). Cleavage site
                                  1       2        3    4         >              remove fragment Mr -3500 parent
                                                                                 protein. assume fragment accounts                                                                                   estimated Mr 2000 difference p31 or29                                                                                   Mr 4000 difference p25 P2l calcu-
                                                                                  lated based gel migration properties. specula-
                    P31-
                                                                                  tions correct, formation active cr factor, a29,                                                                                   p31 involve removal equivalent                        (F9                                                        24-amino acid fragment.
                                                                                      Does hypothetically processed amino-terminal se-
                                                                                  quence spoIlIG (p31) resemble processed
                                                                                  proteins? certain similarity pro-
                   P21                                                            karyotic signal sequences involved transport
                                                                                  membranes. known signal sequences,                                                                                   positively charged amino-terminal sequence (amino acids
                                                                                  1-5), region relatively rich hydrophobic amino acids
                                                                                  (amino acids 6-21), amino acid small R group
      FIG. 4.      Complementation p31/cr pGSlIG11. Crude pro-            (serine) near proposed cleavage site (20). similarity
tein extracts        prepared analyzed described Fig. 1.           intriguing given report 61  e., r'2) compart-
Lanes        1      2, BS50/pGSIIG11 DS medium (15) T2 T3.5,           mentalized fores ores (14). sequence plays respectively; lane 3, SMY (Spo') T2 DS medium; lane 4, E. coli                 role targeting v9 developing forespore. Alterna-
strain C600/pGS1IG11 mid-logarithmic phase LB medium; lane 5,                  tively, resemblance region P31, suggested E. coli strain C600 mid-logarithmic phase LB medium (15).                      lost processing, prokaryotic signal sequences 4192     Genetics: Trempy          et   al.                                                                       Proc. Natl. Acad. Sci. USA 82 (1985)
                               1         2         3        4        5         6         7         8         9         10      11    12
                          fMet          Lys    Lys      Leu      Lys           Leu Arg             Leu Thr                Leu Trp


                          13        14        15       16       17       18        19        20        21        22     23      24
                                                                                                                                     +    25
                         Tyr        Lys       Leu      Leu      Met      Lys       Leu       Gly       Leu       Lys    Ser    Asp        Glu
  FIG. 5. Amino acid sequence amino-terminal portion spolIG protein. amino-terminal sequence spolIG protein predicted Stragier et al. (12) illustrated, arrow indicating predicted S. aureus protease site mimics p3' 0 29 conversion.

reflect structural feature proteins proteolytically                             6. Linn, T., Greenleaf,  L. & Losick, R. (1975) J. Biol. Chem.
processed indicate particular protein                                   250, 9256-9261.
transported.                                                                                  7. Fukuda, R. & Doi, R. (1977) J. Bacteriol. 129, 422-432.
   Unraveling relationship P31 o.29 likely                              8. Trempy, J. E., Morrison-Plummer, J. & Haldenwang, W. G.
reveal mechanisms ofgene control uniquely suited                                     (1985) J. Bacteriol. 161, 340-346.
                                                                                              9. Trempy, J. E., 